Rock Springs Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Rock Springs Capital Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,200,000	Closed	-$2.4M	–	145
2019 Q3	$2.4M	Hold	1,200,000	–	–	0.1%	123
2019 Q2	$2.59M	Hold	1,200,000	–	–	0.09%	123
2019 Q1	$3.79M	Hold	1,200,000	–	–	0.15%	112
2018 Q4	$2.99M	Hold	1,200,000	–	–	0.14%	115
2018 Q3	$4.82M	Hold	1,200,000	–	–	0.17%	120
2018 Q2	$4.54M	Hold	1,200,000	–	–	0.17%	122
2018 Q1	$2.78M	Hold	1,200,000	–	–	0.12%	135
2017 Q4	$1.86M	Hold	1,200,000	–	–	0.08%	133
2017 Q3	$2.57M	Hold	1,200,000	–	–	0.12%	123
2017 Q2	$5.42M	Hold	1,200,000	–	–	0.27%	95
2017 Q1	$3.61M	Hold	1,200,000	–	–	0.21%	101
2016 Q4	$3.31M	Hold	1,200,000	–	–	0.22%	95
2016 Q3	$3.75M	Hold	1,200,000	–	–	0.24%	102
2016 Q2	$6.14M	Buy	1,200,000 +10,000	+0.8%	+$48K	0.45%	71
2016 Q1	$4.87M	Hold	1,190,000	–	–	0.41%	80
2015 Q4	$9.65M	Hold	1,190,000	–	–	0.73%	47
2015 Q3	$10M	Buy	1,190,000 +565,000	+90%	+$5.2M	0.82%	43
2015 Q2	$5.88M	Buy	625,000 +60,000	+11%	+$559K	0.43%	80
2015 Q1	$5.23M	Buy	+565,000	New	+$5.41M	0.49%	70

Other funds holding CORV

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rock Springs Capital Management's CORV Position: Q4 2019 in Review

Rock Springs Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 1,200,000 shares — an estimated $2.4M sold.

Rock Springs Capital Management first reported a position in CORV in Q1 2015 and held it in 19 quarters. The position peaked at $10M in Q3 2015. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

Rock Springs Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
Rock Springs Capital Management sold 1,200,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $2.4M.
Rock Springs Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2015 and held it in 19 quarters.
Rock Springs Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $10M in Q3 2015.
31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Rock Springs Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.